Impact of Chemotherapy Dose Intensity on Ovarian Cancer Outcomes
Author Information
Author(s): V. Torril, E.L. Korn, R. Simon
Primary Institution: Instituto di Ricerche Farmacologiche 'Mario Negri'
Hypothesis
Does chemotherapy dose intensity influence treatment outcomes in advanced ovarian cancer?
Conclusion
Higher chemotherapy dose intensity is associated with improved response rates and median survival in advanced ovarian cancer patients.
Supporting Evidence
- An increase in total dose intensity improved objective response rates by 12% to 16%.
- Median survival increased by 2 to 4 months with higher dose intensity.
- Regression analysis showed a significant relationship between dose intensity and both response and survival outcomes.
Takeaway
Giving more medicine over time can help women with advanced ovarian cancer feel better and live longer.
Methodology
The study analyzed randomized trials of first-line chemotherapy for advanced ovarian cancer published between 1975 and 1989, using weighted regression models to assess the relationship between dose intensity and treatment outcomes.
Potential Biases
Potential biases include selection of better prognosis patients for more intensive regimens and publication bias favoring positive results.
Limitations
The study relied on published data, which may be affected by publication bias, and did not evaluate synergistic effects or schedule dependencies of drug combinations.
Participant Demographics
The study focused on women with advanced ovarian cancer, but specific demographic details were not provided.
Statistical Information
P-Value
0.0008
Confidence Interval
90% CI: 48%-63%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website